ProLung

757 East South Temple
Suite 150
Salt Lake City
Utah
84102-1230
United States

Tel: 801-736-0729
Fax: 801-906-0333

Email: info@prolungdx.com

Show jobs for this employer

About ProLung

ProLung's mission is to make a difference in time for lung cancer patients. ProLung is a leader in innovative predictive analytics technology and non-invasive biomarkers for the risk stratification of lung cancer. The Company develops, tests, and commercializes solutions which may shorten the time to diagnosis and expand the therapeutic window for lung cancer patients. ProLung's predictive analytics platform for lung cancer risk stratification is approved for sale in the European Economic Area and for investigational use only in the US.
YEAR FOUNDED:
2014
LEADERSHIP:
President and CEO: Steven C. Eror
COO: Michael A. Garff
CMO: Jeff O’Driscoll, MD
Chairman of the Board: Todd Morgan
TECHNOLOGY:
Please click here for ProLung's technology.
PIPELINE:
Please click here for ProLung's pipeline.

11 articles about ProLung